CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
for Relapsed/Refractory Multiple Myeloma
16 locations incl. Birmingham
Sponsor: Caribou Biosciences, Inc.
Sex: All·Age: 18+
Code: NCT05722418·Phase 1·Recruiting